CONTENTS:
Each injection contains:
35.2 mg of Sodium Hyaluronate
77 mg of Mannitol
INDICATIONS:
HAppyCross® is indicated as an intra-articular injection in the treatment of pain due to osteoarthritis in the joints such as osteoarthritis of the knee, osteoarthritis of the hip particularly after failure of or intolerance to analgesics (NSAIDs, SAIDs), and in any pain or limitation of mobility of degenerative or traumatic origin in other joints
CONTRAINDICATIONS:
Known sensitivity to one of the components of HAppyCross® (especially hyaluronic acid and/or mannitol)
Pre-existing skin conditions in the area of the planned injection site
Pathologies with auto-immune mechanisms (Acute Rheumatic Fever, Rheumatoid Arthritis)
Inflammatory flare-up of osteoarthritis
Septic arthritis
Haemostatic disorder, lymphatic or venous stasis
